Rather the low intensities or even diminished presence of MBP peptides in samples from mice subjected to stroke and treated with linagliptin, mirror altered proteolytic activities or insusceptibility to processing of MBP due to e.g. Calmodulin binding [40] as a second-tier effect (see below) analog to NEUG. This evidence concerns the gene MBP and Stroke.